VCAM-1-binding peptide targeted cationic liposomes containing NLRP3 siRNA to modulate LDL transcytosis as a novel therapy for experimental atherosclerosis

Xiong Jia(Jinan University), Xiangli Bai(Huazhong University of Science and Technology), Xiaoyan Yang(Huazhong University of Science and Technology), Ling Wang(Huazhong University of Science and Technology), Yajing Lu(Huazhong University of Science and Technology), Lin Zhu(Huazhong University of Science and Technology), Ying Zhao(Huazhong University of Science and Technology), Wenzhuo Cheng(Huazhong University of Science and Technology), Meng Shu(Huazhong University of Science and Technology), Qiyong Mei(Second Military Medical University), Si Jin(Huazhong University of Science and Technology)
Metabolism
July 30, 2022
10.1016/j.metabol.2022.155274
Cited by 35

Abstract

Related Papers

Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
Brian A. Ference, Henry N. Ginsberg, Ian Graham et al.|European Heart Journal|2017|3.8k
NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Alena Grebe, Florian Hoß, Eicke Latz|Circulation Research|2018|914
Breaking down the barriers: siRNA delivery and endosome escape
Monika Domińska, Derek M. Dykxhoorn|Journal of Cell Science|2010|624
Partial carotid ligation is a model of acutely induced disturbed flow, leading to rapid endothelial dysfunction and atherosclerosis
Douglas Nam, Chih‐Wen Ni, Amir Rezvan et al.|American Journal of Physiology-Heart and Circulatory Physiology|2009|500
Current role of the NLRP3 inflammasome on obesity and insulin resistance: A systematic review
Jakeline Rheinheimer, Bianca Marmontel de Souza, Natali S. Cardoso et al.|Metabolism|2017|265